title: Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors.
authors.forename: P
authors.initials: P
authors.lastname: Beauverie
authors.forename: A M
authors.initials: AM
authors.lastname: Taburet
authors.forename: M C
authors.initials: MC
authors.lastname: Dessalles
authors.forename: V
authors.initials: V
authors.lastname: Furlan
authors.forename: D
authors.initials: D
authors.lastname: Touzeau
mesh_terms: D000328:Adult; D004347:Drug Interactions; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008691:Methadone / Q000378:metabolism* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000534:rehabilitation*
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D008691:Methadone